Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medirom Healthcare Technologies (MRM) Current Deferred Revenue (2019 - 2025)

Historic Current Deferred Revenue for Medirom Healthcare Technologies (MRM) over the last 7 years, with Q2 2025 value amounting to $145160.9.

  • Medirom Healthcare Technologies' Current Deferred Revenue rose 13999.04% to $145160.9 in Q2 2025 from the same period last year, while for Jun 2025 it was $145160.9, marking a year-over-year increase of 13999.04%. This contributed to the annual value of $351812.3 for FY2024, which is 5242.48% down from last year.
  • As of Q2 2025, Medirom Healthcare Technologies' Current Deferred Revenue stood at $145160.9, which was up 13999.04% from $351812.3 recorded in Q4 2024.
  • Over the past 5 years, Medirom Healthcare Technologies' Current Deferred Revenue peaked at $916515.7 during Q4 2021, and registered a low of -$1.1 million during Q2 2021.
  • Over the past 5 years, Medirom Healthcare Technologies' median Current Deferred Revenue value was $145160.9 (recorded in 2025), while the average stood at $56117.5.
  • As far as peak fluctuations go, Medirom Healthcare Technologies' Current Deferred Revenue tumbled by 16382.04% in 2022, and later skyrocketed by 28332.98% in 2023.
  • Quarter analysis of 5 years shows Medirom Healthcare Technologies' Current Deferred Revenue stood at $916515.7 in 2021, then tumbled by 163.82% to -$584923.9 in 2022, then surged by 226.42% to $739487.3 in 2023, then tumbled by 52.42% to $351812.3 in 2024, then plummeted by 58.74% to $145160.9 in 2025.
  • Its last three reported values are $145160.9 in Q2 2025, $351812.3 for Q4 2024, and -$362988.9 during Q2 2024.